Enlivex Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Public Companies | 0 | 0% |
Institutions | 629,685 | 3.02% |
Individual Insiders | 1,228,493 | 5.89% |
VC/PE Firms | 1,421,326 | 6.81% |
General Public | 17,592,276 | 84.3% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 12.4%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
1,421,326 | US$1.9m | 0.24% | 1.34% | |||
774,033 | US$1.1m | 2.69% | no data | |||
242,345 | US$332.0k | 3.28% | no data | |||
179,540 | US$246.0k | 0% | no data | |||
73,646 | US$100.9k | 10.2% | no data | |||
72,120 | US$98.8k | 62.2% | no data | |||
69,889 | US$95.7k | 12.6% | no data | |||
67,943 | US$93.1k | 143% | no data | |||
55,525 | US$76.1k | 684% | no data | |||
53,842 | US$73.8k | 2.15% | 0.12% | |||
46,766 | US$64.1k | -3.09% | no data | |||
41,750 | US$57.2k | 0% | 0.01% | |||
40,000 | US$54.8k | 0% | 0.01% | |||
28,899 | US$39.6k | 13.4% | no data | |||
25,495 | US$34.9k | 33.1% | no data | |||
18,261 | US$25.0k | 0% | no data | |||
15,775 | US$21.6k | 9.72% | no data | |||
10,420 | US$14.3k | 0% | no data | |||
9,993 | US$13.7k | 0% | no data | |||
7,224 | US$9.9k | 0% | no data | |||
7,151 | US$9.8k | 0% | no data | |||
3,376 | US$4.6k | 0% | no data | |||
3,069 | US$4.2k | -16.2% | no data | |||
3,000 | US$4.1k | 0% | no data | |||
2,861 | US$3.9k | 0% | no data |